loading
Universe Pharmaceuticals Inc stock is traded at $2.85, with a volume of 157.32K. It is down -0.35% in the last 24 hours and down -44.21% over the past month.
See More
Previous Close:
$2.86
Open:
$2.72
24h Volume:
157.32K
Relative Volume:
0.54
Market Cap:
$1.09M
Revenue:
$32.31M
Net Income/Loss:
$-6.16M
P/E Ratio:
-1.6765
EPS:
-1.7
Net Cash Flow:
$1.08M
1W Performance:
-41.24%
1M Performance:
-44.21%
6M Performance:
-97.94%
1Y Performance:
-99.81%
1-Day Range:
Value
$2.51
$3.1323
1-Week Range:
Value
$2.51
$5.57
52-Week Range:
Value
$2.51
$2,592.00

Universe Pharmaceuticals Inc Stock (UPC) Company Profile

Name
Name
Universe Pharmaceuticals Inc
Name
Phone
-
Name
Address
-
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
UPC's Discussions on Twitter

Compare UPC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
UPC
Universe Pharmaceuticals Inc
2.85 1.09M 32.31M -6.16M 1.08M -1.70
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
163.50 72.50B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.98 47.08B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.16 45.99B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.29 17.52B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
312.26 13.78B 2.76B 1.11B 898.10M 22.77

Universe Pharmaceuticals Inc Stock (UPC) Latest News

pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

Universe Pharmaceuticals stock plunges to 52-week low of $3.20 - Investing.com

Apr 01, 2025
pulisher
Mar 21, 2025

Universe Pharmaceuticals stock plunges to 52-week low of $0.08 By Investing.com - Investing.com Australia

Mar 21, 2025
pulisher
Mar 21, 2025

Universe Pharmaceuticals stock plunges to 52-week low of $0.08 - Investing.com

Mar 21, 2025
pulisher
Mar 20, 2025

Universe Pharmaceuticals Announces Share Consolidation - TipRanks

Mar 20, 2025
pulisher
Mar 20, 2025

Universe Pharmaceuticals Plans To Effect Share ConsolidationQuick Facts - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Universe Pharmaceuticals INC Announces Share Consolidation Effective March 24, 2025 - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

NewtekOne, Inc. Closes Private Offering of Senior Unsecured Notes - The Manila Times

Mar 20, 2025
pulisher
Mar 20, 2025

Universe Pharmaceuticals INC Announces Share Consolidation - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

Major Shake-up: Universe Pharmaceuticals Announces 40:1 Share ConsolidationWhat It Means For Investors - StockTitan

Mar 20, 2025
pulisher
Mar 14, 2025

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Mar 14, 2025
pulisher
Mar 14, 2025

Universe Pharmaceuticals stock plunges to 52-week low of $0.1 By Investing.com - Investing.com South Africa

Mar 14, 2025
pulisher
Mar 14, 2025

Universe Pharmaceuticals stock plunges to 52-week low of $0.1 - Investing.com India

Mar 14, 2025
pulisher
Mar 13, 2025

Universe Pharmaceuticals (NYSE:UPC) Trading Down 4.3% – What’s Next? - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Pre-market Movers: HCTI, HEPA, ZYXI, SYRS ... - RTTNews

Mar 12, 2025
pulisher
Mar 11, 2025

Universe Pharmaceuticals Approves Share Consolidation at Extraordinary Meeting - TipRanks

Mar 11, 2025
pulisher
Mar 10, 2025

UPC’s price-to-book ratio: An indicator of the company’s performance - US Post News

Mar 10, 2025
pulisher
Mar 03, 2025

Universe Pharmaceuticals Adjourns Shareholder Meeting Due to Lack of Quorum - TipRanks

Mar 03, 2025
pulisher
Feb 27, 2025

Universe Pharmaceuticals stock plunges to 52-week low of $0.14 - Investing.com India

Feb 27, 2025
pulisher
Feb 27, 2025

Universe Pharmaceuticals stock plunges to 52-week low of $0.14 By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 26, 2025

Universe Pharmaceuticals receives notice from Nasdaq related to delayed annual report - MSN

Feb 26, 2025
pulisher
Feb 26, 2025

Allogene Therapeutics Expands Strategic Partnership with Foresight Diagnostics to Advance Joint Development Activities Outside the US Across Europe, UK, Canada, and Australia - The Manila Times

Feb 26, 2025
pulisher
Feb 25, 2025

Universe Pharmaceuticals faces potential Nasdaq delisting By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Universe Pharmaceuticals faces potential Nasdaq delisting - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report - The Manila Times

Feb 25, 2025
pulisher
Feb 25, 2025

Universe Pharmaceuticals Faces Nasdaq Delisting Risk Due to Delayed Annual Report - TipRanks

Feb 25, 2025
pulisher
Feb 25, 2025

Universe Pharmaceuticals INC Faces Potential Delisting from Nasdaq Due to Delinquent Annual Report Filing - Nasdaq

Feb 25, 2025
pulisher
Feb 25, 2025

Will Universe Pharmaceuticals Survive Nasdaq's Latest Delisting Threat? - StockTitan

Feb 25, 2025
pulisher
Feb 24, 2025

Looking Into Universe Pharmaceuticals's Recent Short Interest - Benzinga

Feb 24, 2025
pulisher
Feb 23, 2025

Promising Chinese Stocks Worth Watching – February 21st - Defense World

Feb 23, 2025
pulisher
Feb 21, 2025

Dow Tumbles Over 700 Points; US Services PMI Falls In February - Benzinga

Feb 21, 2025
pulisher
Feb 21, 2025

Stock market today: Nuburu surged by 81.61% while Aspire Biopharma Holdings plummented by 44.32% in early trading - Business Upturn

Feb 21, 2025
pulisher
Feb 21, 2025

Why Five9 Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 21, 2025
pulisher
Feb 20, 2025

Universe Pharmaceuticals Adjourns Shareholder Meeting Indefinitely - TipRanks

Feb 20, 2025
pulisher
Feb 18, 2025

Universe Pharmaceuticals Adjourns Extraordinary General Meeting Due to Lack of Quorum - TipRanks

Feb 18, 2025
pulisher
Feb 18, 2025

Volcon, Inc. and GlucoTrack, Inc. See Massive Gains, While Omega Therapeutics and Universe Pharmaceuticals Struggle - HPBL

Feb 18, 2025

Universe Pharmaceuticals Inc Stock (UPC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$10.77
price up icon 4.06%
$32.65
price up icon 0.37%
$97.42
price down icon 0.52%
$8.66
price up icon 0.70%
$108.31
price up icon 1.22%
$312.26
price up icon 1.75%
Cap:     |  Volume (24h):